Mutation in the 26S proteasome regulatory subunit rpn2 gene in Plasmodium falciparum confers resistance to artemisinin

IntroductionMalaria parasites increasingly develop resistance to all drugs available in the market, hampering the goal of reducing malaria burden.MethodsHerein, we evaluated the impact of a single-nucleotide variant, E738K, present in the 26S proteasome regulatory subunit rpn2 gene, identified in Pl...

Full description

Bibliographic Details
Main Authors: Adriana F. Gonçalves, Ana Lima-Pinheiro, Miguel Teixeira, Gustavo Capatti Cassiano, Pedro Cravo, Pedro E. Ferreira
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2024.1342856/full
_version_ 1827355161863913472
author Adriana F. Gonçalves
Adriana F. Gonçalves
Ana Lima-Pinheiro
Ana Lima-Pinheiro
Miguel Teixeira
Miguel Teixeira
Miguel Teixeira
Gustavo Capatti Cassiano
Pedro Cravo
Pedro E. Ferreira
Pedro E. Ferreira
author_facet Adriana F. Gonçalves
Adriana F. Gonçalves
Ana Lima-Pinheiro
Ana Lima-Pinheiro
Miguel Teixeira
Miguel Teixeira
Miguel Teixeira
Gustavo Capatti Cassiano
Pedro Cravo
Pedro E. Ferreira
Pedro E. Ferreira
author_sort Adriana F. Gonçalves
collection DOAJ
description IntroductionMalaria parasites increasingly develop resistance to all drugs available in the market, hampering the goal of reducing malaria burden.MethodsHerein, we evaluated the impact of a single-nucleotide variant, E738K, present in the 26S proteasome regulatory subunit rpn2 gene, identified in Plasmodium chabaudi resistant parasites. Plasmids carrying a functional rpn2 interspecies chimeric gene with 5’ recombination region from P. falciparum and 3’ from P. chabaudi were constructed and transfected into Dd2 P. falciparum parasites.Results and discussionThe 738K variant parasite line presented increased parasite survival when subjected to dihydroartemisinin (DHA), as well as increased chymotrypsin-like activity and decreased accumulation of polyubiquitinated proteins. We thus conclude that the ubiquitin-proteasome pathway, including the 738K variant, play an important role in parasite response to DHA, being the first report of a mutation in a potential DHA drug target enhancing parasite survival and contributing to a significant advance in the understanding the biology of artemisinin resistance.
first_indexed 2024-03-08T04:06:35Z
format Article
id doaj.art-660c206067114734948c3e132a0d0834
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-03-08T04:06:35Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-660c206067114734948c3e132a0d08342024-02-09T05:00:05ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882024-02-011410.3389/fcimb.2024.13428561342856Mutation in the 26S proteasome regulatory subunit rpn2 gene in Plasmodium falciparum confers resistance to artemisininAdriana F. Gonçalves0Adriana F. Gonçalves1Ana Lima-Pinheiro2Ana Lima-Pinheiro3Miguel Teixeira4Miguel Teixeira5Miguel Teixeira6Gustavo Capatti Cassiano7Pedro Cravo8Pedro E. Ferreira9Pedro E. Ferreira10Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, PortugalLife and Health Sciences Research Institute (ICVS)/ Biomaterials, Biodegradables and Biomimetics Research Group (3B's)-PT Government Associate Laboratory, Braga, PortugalLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, PortugalLife and Health Sciences Research Institute (ICVS)/ Biomaterials, Biodegradables and Biomimetics Research Group (3B's)-PT Government Associate Laboratory, Braga, PortugalLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, PortugalLife and Health Sciences Research Institute (ICVS)/ Biomaterials, Biodegradables and Biomimetics Research Group (3B's)-PT Government Associate Laboratory, Braga, PortugalDepartment of Protection of Specific Crops, InnovPlantProtect Collaborative Laboratory, Elvas, PortugalGlobal Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Instituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa (UNL), Lisbon, PortugalGlobal Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Instituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa (UNL), Lisbon, PortugalLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, PortugalLife and Health Sciences Research Institute (ICVS)/ Biomaterials, Biodegradables and Biomimetics Research Group (3B's)-PT Government Associate Laboratory, Braga, PortugalIntroductionMalaria parasites increasingly develop resistance to all drugs available in the market, hampering the goal of reducing malaria burden.MethodsHerein, we evaluated the impact of a single-nucleotide variant, E738K, present in the 26S proteasome regulatory subunit rpn2 gene, identified in Plasmodium chabaudi resistant parasites. Plasmids carrying a functional rpn2 interspecies chimeric gene with 5’ recombination region from P. falciparum and 3’ from P. chabaudi were constructed and transfected into Dd2 P. falciparum parasites.Results and discussionThe 738K variant parasite line presented increased parasite survival when subjected to dihydroartemisinin (DHA), as well as increased chymotrypsin-like activity and decreased accumulation of polyubiquitinated proteins. We thus conclude that the ubiquitin-proteasome pathway, including the 738K variant, play an important role in parasite response to DHA, being the first report of a mutation in a potential DHA drug target enhancing parasite survival and contributing to a significant advance in the understanding the biology of artemisinin resistance.https://www.frontiersin.org/articles/10.3389/fcimb.2024.1342856/fullmalariaPlasmodium falciparumdrug resistanceproteasomegenetic engineeringartemisinin
spellingShingle Adriana F. Gonçalves
Adriana F. Gonçalves
Ana Lima-Pinheiro
Ana Lima-Pinheiro
Miguel Teixeira
Miguel Teixeira
Miguel Teixeira
Gustavo Capatti Cassiano
Pedro Cravo
Pedro E. Ferreira
Pedro E. Ferreira
Mutation in the 26S proteasome regulatory subunit rpn2 gene in Plasmodium falciparum confers resistance to artemisinin
Frontiers in Cellular and Infection Microbiology
malaria
Plasmodium falciparum
drug resistance
proteasome
genetic engineering
artemisinin
title Mutation in the 26S proteasome regulatory subunit rpn2 gene in Plasmodium falciparum confers resistance to artemisinin
title_full Mutation in the 26S proteasome regulatory subunit rpn2 gene in Plasmodium falciparum confers resistance to artemisinin
title_fullStr Mutation in the 26S proteasome regulatory subunit rpn2 gene in Plasmodium falciparum confers resistance to artemisinin
title_full_unstemmed Mutation in the 26S proteasome regulatory subunit rpn2 gene in Plasmodium falciparum confers resistance to artemisinin
title_short Mutation in the 26S proteasome regulatory subunit rpn2 gene in Plasmodium falciparum confers resistance to artemisinin
title_sort mutation in the 26s proteasome regulatory subunit rpn2 gene in plasmodium falciparum confers resistance to artemisinin
topic malaria
Plasmodium falciparum
drug resistance
proteasome
genetic engineering
artemisinin
url https://www.frontiersin.org/articles/10.3389/fcimb.2024.1342856/full
work_keys_str_mv AT adrianafgoncalves mutationinthe26sproteasomeregulatorysubunitrpn2geneinplasmodiumfalciparumconfersresistancetoartemisinin
AT adrianafgoncalves mutationinthe26sproteasomeregulatorysubunitrpn2geneinplasmodiumfalciparumconfersresistancetoartemisinin
AT analimapinheiro mutationinthe26sproteasomeregulatorysubunitrpn2geneinplasmodiumfalciparumconfersresistancetoartemisinin
AT analimapinheiro mutationinthe26sproteasomeregulatorysubunitrpn2geneinplasmodiumfalciparumconfersresistancetoartemisinin
AT miguelteixeira mutationinthe26sproteasomeregulatorysubunitrpn2geneinplasmodiumfalciparumconfersresistancetoartemisinin
AT miguelteixeira mutationinthe26sproteasomeregulatorysubunitrpn2geneinplasmodiumfalciparumconfersresistancetoartemisinin
AT miguelteixeira mutationinthe26sproteasomeregulatorysubunitrpn2geneinplasmodiumfalciparumconfersresistancetoartemisinin
AT gustavocapatticassiano mutationinthe26sproteasomeregulatorysubunitrpn2geneinplasmodiumfalciparumconfersresistancetoartemisinin
AT pedrocravo mutationinthe26sproteasomeregulatorysubunitrpn2geneinplasmodiumfalciparumconfersresistancetoartemisinin
AT pedroeferreira mutationinthe26sproteasomeregulatorysubunitrpn2geneinplasmodiumfalciparumconfersresistancetoartemisinin
AT pedroeferreira mutationinthe26sproteasomeregulatorysubunitrpn2geneinplasmodiumfalciparumconfersresistancetoartemisinin